Heron Therapeutics: Q2 Earnings Snapshot
In this article:
SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Monday reported a loss of $42.1 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of 35 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The pharmaceutical company posted revenue of $31.8 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX
